Xcell Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 71

Employees

  • Stock Symbol
  • 373110

Stock Symbol

  • Share Price
  • $0.65
  • (As of Friday Closing)

Xcell General Information

Description

Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Contact Information

Website
www.xcell.co.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 333, Yeongdong-daero
  • Gangnam-gu
  • Seoul, 06188
  • South Korea
+82
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 333, Yeongdong-daero
  • Gangnam-gu
  • Seoul, 06188
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xcell Stock Performance

As of 13-Nov-2026, Xcell’s stock price is $0.65. Its current market cap is $11.2M with 17.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.65 $0.63 $0.56 - $1.47 $11.2M 17.3M 210K -$0.60

Xcell Financials Summary

As of 30-Jun-2026, Xcell has a trailing 12-month revenue of $3M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 12,800 17,930 25,968
Revenue 3,002 1,370 1,418 860
EBITDA (6,845) (6,560) (5,927) (5,912)
Net Income (7,831) (7,678) (6,994) (7,098)
Total Assets 8,184 10,918 11,466 8,123
Total Debt 3,489 3,810 3,871 5,048
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Xcell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xcell‘s full profile, request access.

Request a free trial

Xcell Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Xcell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024262898-A1 Platform for designing medium composition that is customizable to cell characteristics Inactive 20-Jun-2023
WO-2024262895-A1 Medium composition for culturing nk cells Inactive 19-Jun-2023
WO-2024262894-A1 Medium composition for culturing t cells Inactive 19-Jun-2023
US-20220235317-A1 Composition for inhibiting extension of population doubling time of stem cells, comprising c-met agonist antibody as active ingredient Inactive 28-Jan-2021
EP-4239057-A1 Culture medium composition for establishing or culturing keratinocytes comprising calcium, epideral growth factor, and albumin Inactive 27-Nov-2020 C12N5/0629
To view Xcell’s complete patent history, request access »

Xcell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xcell Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xcell‘s full profile, request access.

Request a free trial

Xcell ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Xcell’s complete esg history, request access »

Xcell FAQs

  • When was Xcell founded?

    Xcell was founded in 2015.

  • Where is Xcell headquartered?

    Xcell is headquartered in Seoul, South Korea.

  • What is the size of Xcell?

    Xcell has 71 total employees.

  • What industry is Xcell in?

    Xcell’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Xcell a private or public company?

    Xcell is a Public company.

  • What is Xcell’s stock symbol?

    The ticker symbol for Xcell is 373110.

  • What is the current stock price of Xcell?

    As of 13-Nov-2026 the stock price of Xcell is $0.65.

  • What is the current market cap of Xcell?

    The current market capitalization of Xcell is $11.2M.

  • What is Xcell’s current revenue?

    The trailing twelve month revenue for Xcell is $3M.

  • What is Xcell’s annual earnings per share (EPS)?

    Xcell’s EPS for 12 months was -$0.60.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process